Compass Therapeutics (CMPX) Interest Coverage Ratio (2018 - 2026)
Compass Therapeutics (CMPX) reported Interest Coverage Ratio of 0.63 for Q1 2026, up 92.53% on a YoY basis from 0.32 in Q1 2025, and up 99.65% sequentially from 179.9 in Q4 2025.
Compass Therapeutics (CMPX) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Compass Therapeutics (CMPX) has 9 years of Interest Coverage Ratio data on file, last reported at 0.63 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 92.53% year-over-year to 0.63; the trailing twelve-month figure through Mar 2026 stood at 2.31 (up 91.96% YoY), and the FY2025 full-year result was 0.92, up 3.36% from the prior year.
- Interest Coverage Ratio rose to 0.63 in Q1 2026, from 179.9 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.63 in Q1 2026 to a low of 179.9 in Q4 2025.
- A 5-year average of 49.87 and a median of 22.15 in 2022 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio tumbled 2700.98% in 2024 and surged 98.02% in 2025, its largest moves.
- Tracing CMPX's Interest Coverage Ratio over 5 years: stood at 42.96 in 2022, then plunged by 258.31% to 153.93 in 2023, then jumped by 95.58% to 6.8 in 2024, then sank by 2545.8% to 179.9 in 2025, then jumped by 99.65% to 0.63 in 2026.
- Business Quant data shows CMPX's Interest Coverage Ratio at 0.63 in Q1 2026, 179.9 in Q4 2025, and 1.36 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Compass Therapeutics | 395.17 Mn | 200.48 Mn | - | -0.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.63 |
| Dec 31, 2025 | -179.90 |
| Sep 30, 2025 | -1.36 |
| Jun 30, 2025 | -2.98 |
| Mar 31, 2025 | -8.37 |
| Sep 30, 2024 | -6.80 |
| Jun 30, 2024 | -150.45 |
| Mar 31, 2024 | -20.37 |
| Dec 31, 2023 | -153.93 |
| Sep 30, 2023 | -115.79 |
| Jun 30, 2023 | -5.37 |
| Mar 31, 2023 | -32.37 |
| Dec 31, 2022 | -42.96 |
| Sep 30, 2022 | -41.99 |
| Jun 30, 2022 | -10.71 |
| Mar 31, 2022 | -23.94 |
| Dec 31, 2021 | -333.36 |
| Sep 30, 2021 | -4.24 |
| Mar 31, 2021 | -51.68 |
| Sep 30, 2020 | -27.21 |